Insufficient scRNA-seq data for expression of OPRPN at single-cell level.
Insufficient scRNA-seq data for expression of OPRPN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 52% | 385.83 | 240 / 459 | 31% | 25.14 | 342 / 1118 |
liver | 41% | 9.10 | 92 / 226 | 36% | 12.76 | 146 / 406 |
skin | 23% | 5.01 | 423 / 1809 | 0% | 0.02 | 2 / 472 |
ovary | 1% | 0.12 | 1 / 180 | 4% | 3.92 | 16 / 430 |
prostate | 3% | 0.47 | 8 / 245 | 0% | 0 | 0 / 502 |
uterus | 1% | 0.77 | 1 / 170 | 2% | 0.63 | 9 / 459 |
esophagus | 2% | 0.68 | 25 / 1445 | 1% | 0.01 | 1 / 183 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
lung | 1% | 0.04 | 3 / 578 | 1% | 0.08 | 12 / 1155 |
pancreas | 1% | 0.41 | 3 / 328 | 1% | 0.03 | 1 / 178 |
peripheral blood | 1% | 0.20 | 13 / 929 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.29 | 4 / 653 | 1% | 0.01 | 4 / 605 |
kidney | 1% | 0.08 | 1 / 89 | 0% | 0.01 | 1 / 901 |
adipose | 1% | 0.33 | 13 / 1204 | 0% | 0 | 0 / 0 |
intestine | 0% | 0.04 | 3 / 966 | 1% | 0.03 | 3 / 527 |
adrenal gland | 1% | 4.76 | 2 / 258 | 0% | 0 | 0 / 230 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
spleen | 0% | 0.03 | 1 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.05 | 5 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.54 | 3 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.06 | 2 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 0.03 | 6 / 2642 | 0% | 0 | 0 / 705 |
bladder | 0% | 0 | 0 / 21 | 0% | 0.00 | 1 / 504 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051930 | Biological process | regulation of sensory perception of pain |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0004866 | Molecular function | endopeptidase inhibitor activity |
GO_0030414 | Molecular function | peptidase inhibitor activity |
Gene name | OPRPN |
Protein name | Opiorphin prepropeptide (Basic proline-rich lacrimal protein) (Proline-rich protein 1) (PRL1) [Cleaved into: Opiorphin] |
Synonyms | BPLP PROL1 |
Description | FUNCTION: Opiorphin is an endogenous inhibitor of neprilysin and aminopeptidase N. Inhibits the breakdown of substance P, Mca-BK2 and Met-enkephalin by neprilysin in vitro with IC(50) values of 29 uM, 33 uM and 33 uM respectively. Inhibits the breakdown of Ala-pNA by aminopeptidase N in vitro with an IC(50) of 65 uM. Has a potent analgesic effect when administered to rats by intravenous injection. . |
Accessions | Q99935 ENST00000399575.7 |